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Abstract 
Objectives: Describe the overweight frequency (overweight and obesity) and identify the factors associated with 
this in children and adolescents with type 1 diabetes mellitus (T1DM) treated at a University Children’s Hospital in Rio 
de Janeiro.
Methods: This is an analytical cross-sectional study, which included patients diagnosed with T1DM who had com-
plete anthropometric data (weight and height) and excluded those using drugs with effect on weight gain, genetic 
syndromes, celiac disease, hypothyroidism, renal failure and other chronic diseases, and pregnant women. The data 
collection was referring to the last consultation, and with respect to laboratory tests, the most recent data was col-
lected. The dependent variable was the overweight, defined as Z score ≥1. The independent variables were gender, 
age, insulin dose, duration of disease, lipid profile, glycated hemoglobin, type of prescribed food planning, and place 
of residence. A logistic regression model was built for each outcome studied, considering significant associations 
those with p < 0.05.
Results: The study included 195 patients with a mean age of 10.6 (±3.8) years, and 49.7 % (n = 97) aged less than 
10 years. The overweight frequency was 40 % (n = 78). The age ≥10 years (OR 0.41; 95 % CI 0.20–0.86; p = 0.019) and 
the dose of insulin/kg ideal weight (OR 3.38; 95 % CI 1:55–7:39; p = 0.002) were considered the variables associated 
with overweight.
Conclusions: There was a high prevalence of overweight, which explains strategies for promoting healthy eating 
habits and changing lifestyle with a focus on children and adolescents with diabetes.
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Background
Historically, due to acute lack of insulin production, 
type 1 diabetes mellitus (T1DM) was associated with 
severe emaciation diagnosis. However, with the world-
wide overweight epidemic in recent decades, there was 
an increase in the incidence of type 2 diabetes mellitus 
(T2DM), especially in adolescents, making it as com-
mon as type 1 in this age group in some countries [1, 2]. 
Consequently, there were also changes in the nutritional 
status of children and adolescents with T1DM, which 
may be overweight at the beginning, hindering the differ-
ential diagnosis between the two types of diabetes 1.
In a cohort study conducted in the United States, with 
children and adolescents with type 1 diabetes, a preva-
lence of 38.5  % of overweight was found, showing that 
the prevalence of overweight and obesity in children 
and adolescents with type 1 diabetes is increasing as in 
the general population [3]. Another American study 
called SEARCH found a prevalence of overweight of 34 % 
among young people with type 1 diabetes, not differing 
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These data corroborate the global trend of increase of 
overweight in children, including the diabetic population, 
as evidenced by Libman et al. [5] who observed a three-
fold increase in the prevalence of overweight in two con-
secutive decades. Certainly, the presence of overweight is 
noteworthy since in addition to increasing cardiovascular 
risk, it increases insulin resistance, which can intensify 
complications in the short and long term, influencing the 
diabetes treatment [4].
In patients with type 1 diabetes, the risk factors for 
developing cardiovascular diseases begin in childhood 
and can persist into adulthood. Studies have shown the 
early onset of severe atherosclerosis in children with type 
1 diabetes compared to healthy children due to damage 
caused by high blood glucose [6, 7].
It is believed that excess weight can be explained by 
high doses of insulin, lifestyle changes, especially those 
related to food intake and reducing energy expenditure, 
and high levels of growth hormone [8, 9]. Moreover, 
recent evidence highlights that overweight is not associ-
ated only with T2DM, because patients with T1DM may 
also have insulin resistance [9, 10].
Modern therapies with flexible schemes of insulin ther-
apy resulted in less restrictive diet, which can represent 
less healthy food choices [11, 12]. Therefore, young peo-
ple with T1DM should be advised about the conscious 
use of the method [13, 14].
Given the above, the objective of this study was to 
describe the frequency of overweight (overweight and 
obesity) and identify the factors associated with this in 
children and adolescents with type 1 diabetes treated at 
the Pediatric University Hospital of Rio de Janeiro.
Methods
This is an analytical cross-sectional study based on ret-
rospective data of children and adolescents diagnosed 
with T1DM assisted in the Diabetes Clinic of a Uni-
versity Children’s Hospital in the city of Rio de Janeiro. 
That clinic is reference center for the treatment of chil-
dren and adolescents with diabetes in the city of Rio de 
Janeiro, consisting of a multidisciplinary team of pediat-
ric endocrinologists, nutritionists, nurses, social workers 
and psychologists.
The study included all patients enrolled in the clinic 
database between April 2009 and December 2011, 
diagnosed with T1DM and complete anthropometric 
data (weight and height) recorded in the database, and 
excluded those users of drugs with effect on weight gain, 
genetic syndromes, celiac disease, hypothyroidism, renal 
failure, or other chronic diseases, pregnant women and 
patients with incomplete anthropometric information.
For the nutritional status diagnosis, the body mass 
index (BMI) was used, as recommended by the World 
Health Organization [15, 16] and adopted by the Minis-
try of Health [17]. For the statistical analysis, were cre-
ated the without overweight variable (low weight and 
eutrophia) and the overweight variable (overweight and 
obesity).
The data collection was referring to the last consulta-
tion, and with respect to laboratory tests, the most recent 
data was collected, which according to the routine they 
are requested between consultations. The laboratory 
tests that were used in the analysis were the following: 
HbA1c and lipid profile (total cholesterol, low density 
lipoprotein (LDL), high density lipoprotein (HDL) and 
triglycerides). The HbA1c was measured by the high effi-
ciency liquid chromatography method (HELC), and clas-
sified according to the recommendation by the American 
Diabetes Association [18] as adequate (HbAC1 < 7.5 %) 
and inadequate (HbAC1 ≥ 7.5 %). The lipid profile classi-
fication used was: total cholesterol (desirable if <150 mg/
dL, borderline if between 150 and 169 mg/dl, increased if 
≥170 mg/dL), HDL (desirable if ≥45 mg/dL, inadequate 
if <45 mg/dL), LDL (desirable if <100 mg/dL, borderline 
if between 100 and 129 mg/dl, increased if ≥130 mg/dL), 
and triglycerides (desirable if <100  mg/dL, borderline if 
between 100 and 129 mg/dL, and increased if ≥130 mg/
dL) [19]. However, a variable categorized as presence (at 
least one lipid abnormality) or absence of dyslipidemia 
was created.
The dependent variable in the study was overweight 
(overweight—BMI between 1 and 2 Z score and Obesity 
BMI >2 Z score). The independent variables were: clinical 
characteristics (HbA1c, dyslipidemia, disease duration—
more than 5 years and less than 5 years, and insulin dose 
per kg/ideal weight); diet (type of prescribed meal plan—
traditional method of portions and carbohydrate count-
ing method (CCHO), and sociodemographic (place of 
residence—Rio de Janeiro and adjacent regions, and age 
<10 years and ≥10 years, and gender).
Descriptive statistical procedures were performed. To 
examine the isolated effect of the independent variables 
in overweight, bivariate logistic regression was used. The 
covariates that showed a p ≤ 0.20 value, or the variables 
for potential explanation (which has shown an associa-
tion with overweight in previous studies), were consid-
ered as candidates for remaining in the final model.
In the following analysis, the selection of the variables 
included in the final logistic model was performed by 
automated and manual procedures (Forward and Wald 
test). The interaction of the variables was verified by the 
correlation matrix.
The selection of the final model took into account the 
analysis of residues by graphical observation, deviance 
analysis, statistics and akaike information criteria (AIC), 
as well as clinical and epidemiological significance. We 
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used the 95 % significance level for the estimated calcula-
tion of odds ratio (OR) in binary logistic regression.
The descriptive statistical analysis were performed with 
SPSS software for Windows version 21.0 (SPSS Inc. Chi-
cago, USA) and the others ones in the free software R, 
version 3.0.1, using the epicalc library.
The study was designed respecting the expected ethical 
aspects. It was approved by the Research Ethics Commit-
tee of the institution under protocol number 59/11.
Results
The sample was composed of 195 children and ado-
lescents, of whom 106 (54.4  %) males and 89 (45.6  %) 
females. The mean age was 10.6 (±3.8) years, 49.7  % 
(n = 97) aged less than 10 years. The classification of the 
nutritional state of the sample is shown in Fig.  1, with 
1.0 % (n = 2) with low weight, 59 % (n = 115) eutrophy, 
30.3 % (n = 59) with overweight, and 9.7 % (n = 19) with 
obesity, totaling 40 % (n = 78) with excess weight.
As for HbA1C, 181 individuals had this data, and 49.2 % 
(n = 89) were adequate compared to the values proposed 
as ideal, and the average Hb1Ac 8.07 %. The age at diag-
nosis, disease duration and dose of insulin/kg of ideal 
weight had averages of 5.54 (±2.79) years, 5.58 (±3.37) 
years, and 1.03 (±0.48) units, respectively. In Table 1, the 
average values of total cholesterol, LDL, HDL and triglyc-
erides are represented. Regarding the lipid profile, 42.8 % 
(n = 71) had high total cholesterol, 15.8 % (n = 26) had 
inadequate HDL, 28.5 % (n = 47) and 12.5 % (n = 20) had 
LDL-c and elevated triglycerides, respectively, and 71.5 % 
(n = 125) had some change in the lipid profile.
The dietary planning based on CCHO was followed by 
44.7 % (n = 85), and the method of portions by 55.3 % of 
the patients (n = 105). In the evaluation of the place of 
residence, it was found that the majority 68 % (n = 132) 
lived in the city of Rio de Janeiro.
The logistic regression models, unadjusted and 
adjusted for factors associated with overweight are shown 
in Tables  2 and 3, respectively. After adjusting the vari-
ables, the age ≥10  years was protective, and the higher 
dose of insulin/kg ideal weight increased the chance for 
the overweight. The protection related to age ≥10 years 
is represented by OR 0.41, which showed a relative risk 
lower than half for present overweight, when compared 
to age lower than 10  years. In contrast, higher doses of 
insulin increased more than three times the relative risk 
for overweight, when compared to the lowest dose of 
insulin/kg ideal weight.
Discussion
The prevalence of overweight is high and confirms data 
from national and international studies. It is believed that 
the nutritional status of children and adolescents with 
T1DM reflects the results of the data found in the Brazil-
ian population without T1DM at the same age, charac-
terized by the representative increase of overweight with 
continuous reduction of the prevalence of malnutrition 
[20].
Luczynski et al. [21] in a sample of 500 Polish children 
with T1DM, found a prevalence of 30.2 % of overweight, 
3.2 % of the metabolic syndrome and 4.8 % of hyperten-
sion. In Brazil, Liberatore et  al. [1] and Marques et  al. 
[8] found among children and adolescents with type 
1 diabetes prevalence of overweight of 16 and 14.1  %, 
respectively. These studies differ due to the smaller sam-
ple size, period and criteria adopted for anthropometric 
assessment.
More recently, a large multicenter study in 28 pub-
lic clinics in 20 Brazilian cities, identified an overweight 
Fig. 1 Nutritional status classification of children and adolescents with type 1 diabetes: low weight 1 % (n = 2), eutrophic 59 % (n = 115), 30.3 % 
overweight (n = 59) and obesity 9.7 % (n = 19)
Table 1 Average values of  total cholesterol, LDL-C, HDL-C 
and  triglycerides in  children and  adolescents with  T1DM 
treated at a University Children’s Hospital in Rio de Janeiro
CT total cholesterol; LDL-C low density lipoprotein; HDL-C high density 
lipoprotein; TG triglycerides; SD standard deviation
Lipid fraction n Minimum Maximum Average SD
TC (mg/dL) 166 107 284 167.92 33.53
LDL-c(mg/dL) 165 42 197 87.04 27.98
HDL-c(mg/dL) 165 29 196 64.4 22.90
TG (mg/dL) 160 30 287 78.38 049.43
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prevalence of 31.6  % among individuals with T1DM, 
being mostly in the age group up to 15 years. These data 
are consistent with the Household Budget Survey [22], 
where 33.5 % of children aged 5–10 years were found to 
be overweight, while the prevalence among adolescents 
was 21.5  %. Thus, it is observed that children and ado-
lescents with T1DM are following the epidemiological 
profile of overweight shown by children and adolescents 
without diabetes.
Noteworthy is the high frequency of dyslipidemia, 
consistent with findings in literature. The frequency of 
elevated LDL (>100 mg/dL) in other studies ranges from 
20 to 50 % [4, 23]. However, the literature is poor in rela-
tion to information on the absorption and synthesis of 
cholesterol in T1DM. Also, it is not known the actual 
prevalence of dyslipidemia in children and adolescents 
with this disease, which hinders the study of demograph-
ics, social-economics or ethnic factors associated with it. 
Alves et  al. reported that 32.6  % (n =  49) children and 
adolescents with T1DM and mean HbA1c of 11  % had 
some form of dyslipidemia [23].
The disease duration variable of disease was not asso-
ciated with overweight. However, Jose et  al. [24] found 
association between disease duration and insulin doses 
with worse control of T1DM according to the value of 
HbA1c. This lack of association between disease duration 
and overweight is justified; patients with the disease for 
a longer period of time and adolescents know the symp-
toms and can manage insulin better, so they tend to sub-
tract insulin doses and/or meals as measures to prevent 
undesirable weight gain.
Age ≥10  years was protective to overweight when 
compared to age <10 years, possibly because at the lower 
age range there is a greater fear from parents regarding 
the episodes of hypoglycemia, which leads them to over-
feed these children as prevention. On the other hand, 
the greater insulin dose was associated with overweight, 
which confirms the literature. These results justify fur-
ther specific actions aimed to younger patients’ fam-
ily members and overweight patients because they have 
higher risks of overweight and large doses of insulin, 
respectively, resulting in insulin resistance and increased 
risk of future complications.
Reinehr et  al. [10], in a study including 8156 children 
and adolescents with type 1 diabetes on intensive insulin 
therapy, found a positive association between overweight 
and the daily dose of insulin per kilogram of ideal weight, 
which would explain the insulin resistance in this group 
with T1DM [10]. However, Liberatore et  al. showed no 
association between the dose of insulin and BMI [1].
From a physiological point of view, insulin sensitivity 
must be related to lean body mass, since glucose intake 
occurs predominantly in muscle tissue. The diabetic 
patients that are overweight often require higher doses of 
insulin, since the glucose intake occurs about 75 % in the 
muscle tissue and only 4 % in the fat tissue [1, 10].
Because insulin is the key to the entry of glucose into 
the cell, a greater insulin demand occurs to perform this 
functionin the subjects with excess of fat tissue. This 
process relates to lower glucose intake and consequent 
increased demand for insulin, suggesting that the higher 
the fat mass, the higher the insulin resistance.
Fröhlich-Reiterer et  al. [25] identified the predictor 
factors for BMI increase during the course of diabetes. 
Table 2 Prevalence and unadjusted odds ratios of the fac-
tors associated with  overweight in  children and  adoles-
cents in a University Children’s Hospital in Rio de Janeiro
Variables n OR RI 95 % P
Age (years)
<10 42 1
≥10 36 0.76 0.43–1.35 0.326
Gender
Male 35 1
Female 42 1.81 1.01–3.24 0.044
Place of residence
Rio de Janeiro 50 1
Surroundings 26 1.18 0.64–2.19 0.589
Disease duration (years)
<5 37 1
>5 39 0.92 0.51–1.64 0.772
Dietary planning methods
Portions 40 1
CCHO 35 1.14 0.63–2.04 0.666
HbA1C adequacy
Adequate 30 1
Inadequate 42 1.65 0.9–3.01 0.102
Daily dose of insulin/kg – 2.12 1.13–3.97 0.019
Changes in lipid profile
No 12 1
Yes 50 1.61 0.75–3.45 0.212
Table 3 Odds ratio adjusted for  factors associated 
with overweight in children and adolescents treated at the 
Paediatric University Hospital of Rio de Janeiro
AIC akaike information criterion: 252.81
a Daily dose of insulin per kilogram of ideal body weight
Variables OR RI 95 % P
Age (years)
<10 1
≥10 0.41 0.20–0.86 0.019
Daily dose of insuln/kga 3.38 1.55–7.39 0.002
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For females, low BMI in early diabetes, intensive insulin 
therapy, and higher insulin dose, additionally to longer 
disease duration and age were associated with greater 
increases in BMI.
The same authors suggest that the number of injec-
tions, the amount and type of insulin, are determining 
factors for increased BMI. The reasons for this are prob-
ably the anabolic effect of insulin, which promotes weight 
gain, stimulating the lipogenesis, inhibiting protein 
catabolism and slowing basal metabolism, on one hand, 
and on the other hand, the weight gain is influenced by 
the caloric intake.
Children with intensive insulin therapy are likely to 
have a more flexible eating pattern, which could lead 
to increased risk of overweight. However, our study 
showed no association between the type of diet planning 
and overweight. This fact may be due to the approach 
taken in the CCHO prescription, which emphasizes the 
consumption of healthy foods, regardless of the dietary 
planning method. In addition, studies on nutrition in 
T1DM are scarce, but studies have shown that weight 
gain can also be influenced by diets high in fat and lower 
carbohydrate content to try to avoid insulin injections 
[26, 27].
An American study, with 35 young people between 
8 and 21  years, with T1DM, showed that insulin regi-
mens and more flexible diets are associated, according 
to parents and children, to frequent consumption of 
unhealthy foods such as high calories, low in fiber and 
micronutrients snacks [28]. In Brazil, an epidemiologi-
cal study conducted about diet adherence, cardiovascu-
lar risk and T1DM reported that only 54.2 % of patients 
adhered to the diet prescribed, and those with better 
adherence had lower BMI, improved metabolic control 
(HbA1C and lipid profile), and best pressure level. The 
study also found lower adherence among those with 
high BMI [29].
We can cite as limitations of this study the absence of 
anthropometric measurements, such as waist circumfer-
ence, measures of body composition and level of physi-
cal activity, and for not being a longitudinal study, which 
would allow the assessment of the evolution of anthropo-
metric profile and its relation to the factors studied dur-
ing the treatment.
Conclusions
The increase in prevalence of risk factors associated with 
overweight among children and adolescents is a global 
health problem. As children and adolescents with type 
1 diabetes have also the same risk of developing over-
weight, monitoring weight gain is an important aspect 
in the care of children and adolescents with T1DM. 
Especially among those of younger age and with higher 
doses of insulin. In this context, it is necessary to discuss 
strategies for promoting glycemic control in this group, 
especially in the group of children under 10  years, with 
a focus on lifestyle, which emphasizes the promotion of 
healthy eating habits and physical activity.
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